MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.65 +3.11%

+$0.39 today

Market cap
$283.41M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.42M

Average 0.73M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$169.08M

FY 2025 · Annual

Net Income

-$161.15M

FY 2025 · Annual

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue574K556K701K578K
Gross Profit(574K)(556K)(701K)(578K)
Gross Margin————
Research & Development26.57M49.12M67.82M137.77M
Selling, General & Admin4.1M7.61M14.42M30.73M
Operating Expenses30.67M56.73M82.25M168.51M
Depreciation & Amortization574K556K701K578K
EBITDA(29.44M)(55.15M)(76.88M)(160.57M)
EBITDA Margin————
Operating Income(31.25M)(57.28M)(82.95M)(169.08M)
Operating Margin————
Interest Income429K1.1M4.5M5.52M
Interest Expense0000
Other Income / Expenses1.23M1.57M5.37M7.93M
Income Before Tax(30.02M)(55.71M)(77.58M)(161.15M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(30.02M)(55.71M)(77.58M)(161.15M)
Net Margin————
EPS (Basic)(0.72)(1.34)(1.87)(3.66)
EPS (Diluted)(0.72)(1.34)(1.87)(3.66)
Weighted Avg Shares41.43M41.43M41.43M44.02M
Weighted Avg Shares (Diluted)41.43M41.43M41.43M44.02M

MPLT Earnings Waterfall · TTM

NASDAQ:MPLT · Revenue to Net Income

Key Ratios

EPS$-4.58
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-4.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$199.5M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-4.58, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026
4Statement of changes in beneficial ownershipOct 16, 2026

How much revenue does MPLT generate?

MapLight Therapeutics, Inc. (MPLT) reported $0.00 of revenue in fiscal 2025.

Is MPLT profitable?

MapLight Therapeutics, Inc. (MPLT) reported -$161.15M of net income.